Pneumonia Clinical Trials in Paris
7 recruitingParis, France
Showing 1–7 of 7 trials
Recruiting
Phase 3
Randomised Evaluation of COVID-19 Therapy
Pneumonia
University of Oxford70,000 enrolled16 locationsNCT04381936
Recruiting
Phase 3
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
Community-acquired Pneumonia
Biotest590 enrolled147 locationsNCT05722938
Recruiting
Not Applicable
Immediate Versus Substantiated Antibiotic Therapy in Suspected Non-Severe Ventilator-Associated Pneumonia
Ventilator-Associated Pneumonia (VAP)
Nantes University Hospital686 enrolled41 locationsNCT06743529
Recruiting
Infectious Complications After Esophagectomy
PneumoniaPostoperative ComplicationsEsophagectomy+1 more
Assistance Publique - Hôpitaux de Paris350 enrolled2 locationsNCT06911658
Recruiting
Definition of Sub-phenotypes of Pneumonia Based on the Respiratory Microbiome Composition to Predict Microbial and Clinical Treatment Failures
Community Acquired or Acquiring Hospital Acquired Pneumonia
Assistance Publique - Hôpitaux de Paris300 enrolled6 locationsNCT06916481
Recruiting
Phase 3
Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients
Pneumonia, Ventilator-Associated
Hospices Civils de Lyon132 enrolled9 locationsNCT05843786
Recruiting
Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Community-acquired Pneumonia, Influenza, COVID-19
UMC Utrecht20,000 enrolled408 locationsNCT02735707